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Benzo[ a]pyrene (BP) metabolites conjugated with glutathione, cysteine-glycine, cysteine, 
N-acetylcysteine, and sulfuric and glucuronic acids have been studied by microcolumn 
liquid chromatography-electrospray mass spectrometry with collision-induced dissociation 
(CID) on a hybrid double focusing magnetic sector-orthogonal time-of-flight tandem mass 
spectrometer equipped with a focal plane array detector. Negative-ion electrospray mass 
spectra of the conjugated BP metabolites showed strong [M - HI- ions. When the array 
detector was used, spectra were obtained from femtomoles of sample infused at mass 
resolutions of 5000 (full width at half maximum). Cone voltage fragmentation spectra show 
[M - HI- ions and fragment ions indicative of the BP moiety and/or the conjugating group. 
Linked scan CID spectra at constant B/E were found to contain structurally informative 
product ions from infusion of as little as 1 pmol of sample. CID spectra were also recorded 
by using the double focusing sectors for precursor ion selection and the orthogonal time-of- 
flight analyzer for product ion mass separation. The method was applied to the analysis of 
conjugated BP metabolites in the urine of germ-free rats given a single intraperitoneal dose 
of BP. 0 1997 American Socieg for Mass Spectromety (1 Am Sot Mass Spectrom 1997, 8, 
50-62) 
P 
olycyclic aromatic hydrocarbons @AH) are 
widely distributed in the environment and sus- 
pected to be a significant health risk to humans 
[l]. Benzo[a]pyrene (BP) (Structure 11, one of the most 
studied PAHs, undergoes extensive metabolism to a 
number of compounds, including some highly reactive 
electrophiles that can form covalent bonds with macro- 
molecules, including DNA [2]. Some of these reactive 
intermediates, for example, PB r-7-f-&dihydrodiol-t- 
9,10-epoxide (BPDE) (Structure 2), in particular the 
( +)-enantiomer, have been shown to be potent muta- 
gens and carcinogens in various experimental systems 
[3]. Glucuronidation and sulfation are two major reac- 
tion pathways to convert highly electrophilic interme- 
diates of BP metabolism into water soluble substances 
that can be readily excreted [4]. Glutathione conjuga- 
tion of BP with subsequent formation of mercapturic 
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acid pathway metabolites represents another detoxifi- 
cation pathway which is important in the liver [5]. The 
importance of the mercapturic acid pathway in the in 
vivo metabolism of BP has been reported [6]. Charac- 
terization of BP metabolites has been performed pre- 
dominantly in connection with in vitro experiments. In 
vivo studies have been severely hampered by analyti- 
cal problems caused by the variety, polarity, and low 
concentrations of BP metabolites in biological extracts. 
In an earlier publication from our laboratory, a 
group fractionation procedure was reported as the first 
step in the analysis of BP metabolite mixtures in rate 
excreta [7, 81. This separates neutral or weakly acidic 
unconjugated BP metabolites and different classes of 
intact conjugates of BP metabolites. The pattern of BP 
metabolites observed in vivo was far more complex 
than what can be deduced from previous studies [9, 
lo]. About 18% of the BP derivatives in urine were 
neutral or weakly acidic compounds. Among them, a 
number of novel metabolites were detected by using 
high-performance liquid chromatography (HPLC) and 
gas chromatography-mass spectrometry (GC/MS) 
[II]. Attempts were made to analyze the conjugated 
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BP metabolites that predominate in rate excreta (about 
80% of BP derivatives) by using static and continuous- 
flow fast-atom bombardment mass spectrometry (CF- 
FAB/MS). Because of the complexity of the mixture, 
the instability of some metabolites during the purifica- 
tion process, and an insufficient yield of ions by these 
methods, the analysis of BP conjugates in biological 
fluids has been problematic 112-141. 
Electrospray (ES) [15] is an alternative soft ioniza- 
tion technique that has been widely used in the charac- 
terization of biological substances and perhaps is more 
appropriate for the analysis of conjugated BP metabo- 
lites. When combined with the use of a focal plane 
array detector in a magnetic sector mass spectrometer, 
a great increase in sensitivity may be expected. 
HPLC has been extensively used in the analysis of 
metabolites of xenobiotics, particularly their conju- 
gated forms. Trace analysis with capillary column 
HPLC can be achieved with high column efficiency, 
low sample consumption, and microliter flow rates 
compatible with direct connection to ES or 
continuous-flow fast-atom bombardment (CF-FAB) ion 
sources. Liquid chromatography-mass spectrometry 
(LC/MS) is potentially the most suitable method for 
the analysis of conjugated metabolites of xenobiotics 
and endogenous substances in biological material. In 
our laboratory, capillary liquid chromatography-fast- 
atom bombardment mass spectrometry (LC-FAB/MS) 
and liquid chromatography-electrospray mass spec- 
trometry (LC-ES/MS) have been used to analyze 
metabolites of arachidonic acid [16] and bile acids in 
human urine (Yang, Y.; Griffith, W. J.; Nazer, H.; 
Sjovall, J., unpublished). 
Since CF-FAB/MS did not provide the required 
sensitivity in analyses of conjugated BP metabolites 
1121, in the present study we have investigated the 
possibility that this could be achieved by ES ionization 
alone and in combination with capillary column HPLC. 
The mass spectrometer used was a hybrid magnetic 
sector (EBE) orthogonal time-of-flight (TOF) instru- 
ment equipped with a focal plane array detector (FPD) 
positioned after the magnetic sector [17, 181. 
Studies were performed to determine sensitivities 
and optimum conditions for the identification of uri- 
nary metabolites of BP (Structures 3-14) by using 
electrospray mass spectrometry (ES/MS) with colli- 
sion-induced dissociation (CID). The detection limits 
for a series of conjugated BP metabolites have been 
determined with both point and focal plane array 
detectors. Cone voltage collision-induced dissociation 
(CVCID) spectra, high translational energy CID B/E 
linked scan spectra, and 400-eV orthogonal accelera- 
tion time-of-flight (OATOF) CID spectra have been 
recorded and compared. Capillary column HPLC-ES- 
CID has also been applied to the analysis of conjugated 
BP metabolites in the urine of rats after a single dose of 
BP. However, the thorough characterization of in vivo 
metabolites of BP in both urine and faces of rats given 
BP will be published in separate articles. 
Experimental 
Chemicals 
Analytical grade solvents were redistilled prior to use. 
Water was distilled and deionized in a Miili-Q water 
system (Millipore, Molsheim, France). Racemic BPDE, 
sodium salts of BP-3-ol-/?-D-glucuronide (BP-3-GlcA), 
BP-9-ol-/3-D-glucuronide (BP-9-GlcA), and BP-9-01- 
sulfate (BP-9-SO,) were obtained from the National 
Cancer Institute, Chemical Carcinogens Repositories 
(National Institute of Health, Bethesda, MD). The glu- 
tathione (GSH), cysteinyl-glycine (CysGly), cysteine 
(Cys), and N-acetylcysteine (NAcCys) conjugates of 
BPDE (BPDE-GSH, BPDE-CysGly, BPDE-Cys, and 
BPDE-NAcCys) were synthesized as described previ- 
ously [12]. NAcCys, Cys, CysGly, and GSH conjugates 
of BPDE each eluted, as expected, as two peaks in the 
HPLC chromatograms due to the presence of di- 
astereoisomers. These isomers were not separated from 
the mass spectrometric analysis. 
Animal Treatment 
Germ-free rats were dosed intraperitoneally with a 
mixture of BP (Sigma, St. Louis, MO) and [7,10-i4C] 
labeled BP (Amersham International, England; 16.7 
pg/g body weight) and urine was collected as de- 
scribed previously [ll]. 
Chromatographic System 
The capillary column (0.25 mm i.d. x 500 mm, packed 
with 5-pm Chromasil C,, (Hichrom, Berkshire, UK) as 
described by Alborn and Stenhagen [19]) was con- 
nected to a transfer capillary of fused-silica tubing 
(0.05 mm x 1 m). About 10 mm of the polyimide 
coating of this capillary was removed to provide a 
flow cell for UV detection by using an ISCO detector 
(model CV4, Lincoln, NE) at a wavelength of 254 nm. 
A flow rate of 5 gL/min was generated with a Carlo 
Erba syringe pump (Fisons Instrument, UK) in the 
pressure control mode. The mobile phase consisted of 
60% methanol/water. A Valco (Houston, TX) C6 injec- 
tion valve with an external loop (20 ILL) was used for 
injection of the sample in 2-10 /IL of mobile phase 
containing a higher concentration of water than that 
used in the chromatography to concentrate the ana- 
lytes at the top of the column. 
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Mass Spectromet y 
Negative-ion ES mass spectra were recorded on a VG 
(formerly VG Analytical, now Micromass, Manchester, 
UK) AutoSpec-TOFFPD hybrid mass spectrometer (de- 
scribed fully in refs 17 and 18). The sample solutions of 
HPLC effluents were transferred directly into the elec- 
trospray source. An accelerating voltage of - 4 kV was 
selected and nitrogen was used as the nebulizer and 
bath gas with flow rates of 15 and 250 L/h, respec- 
tively. The bath gas was heated to 80 “C. 
To record spectra by using the point and array 
detectors, the source was tuned to give a maximum 
[M - HI- ion current at a resolution of 1000 (5% 
valley) and 5000 (full width at half maximum), respec- 
tively. 
High translational energy CID spectra were gener- 
ated by using helium as the collision gas in the first 
field-free region gas cell at a pressure that gave a 
reduction of 50% in [M - HI- ion intensity. The labo- 
ratory frame collision energy was 4000 eV. Product 
ion, constant B/E linked scan spectra were recorded 
by using the FPD set at a mass ratio setting of 1.05 : 1 
and with exposure times of 1-2 seconds per exposure. 
To record the CID spectra on the TOF analyzer, the 
EBE section of the AutoSpec mass spectrometer was 
employed as mass spectrometer 1 (MSl) and [M - H]- 
ions were selected and focused into the collision cell 
located just after the collector slit. MS1 was operated at 
a resolution of approximately 1500 (5% valley). The 
cell was floated to -3.6 kV, thereby giving a collision 
energy of 400 eV in the laboratory frame. Xenon was 
used as the collision gas. 
Results and Discussion 
Detection Limits on the Point and Array Detectors 
with Constant Infusion of Conjugated BP 
Metabolites 
As previous mass spectrometric studies of conjugated 
BP-metabolites were ineffective due to insufficient in- 
strumental sensitivity, initial experiments were per- 
formed to determine the optimum conditions and lim- 
its of sensitivity for analysis of such compounds. The 
ES solvent was selected to give maximum intensity of 
the [M - HI- ion. In most cases, this was obtained 
when samples were dissolved in methanol/water (1: 1 
by volume). However, the addition of 1% ammonia 
enhanced the signal 2-3 times for the amphoteric, that 
is, Cys and CysGly, conjugates. When the solvent 
system was acetonitrile/water (1: 1 by volume) or 
50% methanol buffered with 30-mM ammonium ac- 
etate (pH 7.2); used to obtain the best chromatographic 
separation) the [M - HIP ion intensity was 50% of 
that obtained with a - 50% methanol solvent system. 
The detection limits were determined at a constant 
infusion flow rate of 5 pL/min methanol/H,0 (1: 1 
by volume) solvent. Lowering the flow rate from 5 to 2 
pL/min had no noticeable effect on ion current when 
the sampling cone and counter electrode were freshly 
cleaned and the needle was carefully positioned. How- 
ever, there was a reduction in signal stability at low 
flow rates as the counter electrode and cone steadily 
became dirtier. Some instability of the ion current also 
resulted when 30% methanol was used as the solvent. 
Full mass spectra were recorded by using both the 
point and array detectors. Table 1 summarizes the 
results obtained. Detection limits are quoted for a 
minimum of 10 : 1 signal-to-noise ratio and are for the 
amount of infused sample. A full mass spectrum was 
recorded at the point detector in approximately 15 s (1 
min on the FPD) during which time 1.25 PL (5 PL on 
FPD) of sample solution was sprayed into the instru- 
ment. For the GSH conjugate, infusion of 1.4 fmol of 
sample was sufficient to give a full mass spectrum by 
using the FPD, while approximately 100 times more 
sample was required to obtain a similar signal-to-noise 
(S/N) ratio with the point detector. From Table 1 it can 
be seen that by using the FPD rather than the point 
detector, the detection limits for all the BP metabolites 
studied were improved by an order of magnitude. By 
selecting a narrow mass range where the [M - HI- 
ion appears, the amount of sample infused to give a 
spectrum in which the [M - HI- ion dominates can be 
reduced by another factor of 5-10. Although the 
amount of sample infused to record a spectrum is a 
somewhat artificial figure, it is relevant as it indicates 
a lower limit of sample which theoretically can be 
analyzed on the instrument. 
In a previous article we reported on the analysis of 
conjugated BP metabolites by static and continuous- 
flow fast-atom bombardment mass spectrometry 
(FAB/MS) on a VG 70-250 instrument equipped with 
an electron multiplier point detector [12]. With static 
FAB/MS, 4 nmol of material gave S/N ratios of 5 : 1 
Table 1. Detection of BP metabolite conjugates on the point 
and array detectors with constant infusion of sample: the recording 
of full mass spectra at the point detector took approximately 15 s 
(1 min at the FPD) during which time 1.25 PL (5 PL on the FPD) 
was suraved into the instrument 
Sample infused per scan 
BP metabolite conjugate 
BPDE-GSH 
BPDE-NAcCys 
BPDE-CysGly 
BPDE-Cys 
BPDE-Cys (with 1% NH,) 
BP-Sulfate 
BP-Glucuronide 
Point 
50 Pg 
140 fmol 
50 PS 
180 fmol 
Km PS 
1.7 pmol 
5 ng 
20 pmol 
2 ng 
8 pmol 
50 PS 
240 fmol 
mJ Pg 
2 pm01 
Array 
0.5 Pg 
1.4 fmol 
5 Pg 
18 fmol 
5 Pg 
17 fmol 
50 Pg 
200 fmol 
5 Pg 
24 fmol 
50 Pg 
200 fmol 
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for the cysteine conjugates and 20: 1 for the glu- 
tathione conjugates. CF-FAB enhanced the sensitivity 
over static FAB by a factor of 4. With ES as the 
ionization method, the detection limits by using the 
point detector were 50 times lower for the cysteine 
conjugates and over 100 times lower for other conju- 
gated BP metabolites. Further gains in sensitivity were 
obtained by recording ES spectra on the FPD. As a 
consequence of the chemical noise associated with CF- 
FAB, similar gains in sensitivity would not be obtained 
by using the FPD in association with this form of 
ionization. It should also be mentioned that although 
[M - HI- ions were dominated in both FAB and ES 
spectra, FAB/MS gave intense fragment ions indica- 
tive of the BP moiety and conjugating group, while 
there was little fragmentation observed in conven- 
tional ES spectra. 
Capillary Column-High-Performance Liquid 
Chromatography-Electrospray Mass Spectrometry 
of a Mixture of Conjugated BP Metabolites 
The four mercapturic acid pathway BP meta- 
bolites-GSH, CysGly, Cys, and NAcCys conjugates of 
BP-7,8-dihydrodiol-9,10-epoxide-were used in the 
present study to demonstrate the effectiveness of capil- 
lary column-HPLC-ES/MS (high-performance liquid 
chromatography-electrospray mass spectrometry) for 
analysis of conjugated BP metabolites. Gradient elu- 
tion with methanol/water containing 30-mM ammo- 
nium acetate buffer (pH 7.2) was used at a flow rate of 
4 pL/min. Detection limits were also determined by 
using the LC inlet system for the amount of sample 
injected. Detection limits were at picomole levels for 
full mass spectra recorded on the point detector and 
were not greatly dissimilar from those determined by 
continuous infusion. 
4000-eV, 40@eV, and Cone VoItuge Collision- 
Induced Dissociation of BP Metabolite Conjugates 
As outlined in the Experimental section CID spectra 
were recorded at high translational energy (4000 eV) 
by using He as the collision gas. These were linked 
scans at constant B/E and recorded on the FPD. CID 
spectra were also recorded by using the OATOF ana- 
lyzer. In such cases Xe was the collision gas employed 
and the laboratory frame collision energy was 400 eV. 
By using Xe as the collision gas, high center of mass 
collision energies are attained even at intermediate 
laboratory frame collision energies. 
Cone voltage spectra are recorded when the poten- 
tial difference between the sampling cone and the 
skimmer is approximately 300 V. If the sample is pure, 
the mass spectrum recorded will be a CID spectrum of 
the sample. As CVCID occurs without mass selection 
of the precursor ion, the presence of impurities will 
also lead to peaks in the spectrum indistinguishable 
from CVCID fragments. 
The CID spectra presented were recorded with con- 
tinuous infusion of sample, unless otherwise stated. 
Fragmentation Nomenclature 
For a molecule M, the deprotonated molecule [M - 
HI- is represented as ‘M, where the prime to the left 
of the capital letter indicates that the ion is deficient in 
one H compared to the molecular ion. Similarly a 
double prime to the left of the capital letter represent- 
ing a fragmentation process indicates that fragmenta- 
tion proceeds with the resulting fragment ion, for 
example, “X 1 is deficient in two hydrogens as com- 
pared with a fragment ion formed by a homolytic 
fragmentation at the same point in the molecular ion 
M-. Primes to the right indicate the addition of H to 
the fragment. 
The benzdalpyrene moiety is represented by BP 
and the benzo[a]pyrene tetrahydrotriol moiety by A 
(adducting group). 
Peptide fragmentation will be described by using 
the nomenclature of Roepstorff and Fohlman [20]. The 
notation to describe the H transfer upon fragmentation 
will be similar to that proposed by Roepstorff and 
Fohlman. 
Collision-induced Dissociation of BPDE-ZO-GSH 
and BPDE-7-GSH 
CID spectra were recorded for BPDE-lo-GSH and 
BPDE-7-GSH. Shown in Figure la and described in 
Table 2 is the 400-eV CID spectrum of the [M - HI- of 
BPDE-lo-GSH recorded on the OATOF. The resolving 
properties of the EBE sectors of MS1 allow the selec- 
tion of the monoisotopic (i2C> precursor ion. Unit mass 
resolution is achieved on the product ions. A weak 
fragment ion appears at m/z 563 but almost no other 
fragment ions are observed above mass m/z 336. Be- 
low m/z 336, peaks appear at m/z 335 and 334, 
probably corresponding to S-containing polycyclic hy- 
drocarbon ions AS and ‘AS formed by fragmentation 
of the C-S bond of cysteine (Scheme I>, without (AS) 
and with (‘AS) elimination of an H from the ring 
system. Intense fragment ions observed at m/z 305 
(‘7) correspond to distonic glutathionate radical anions 
probably formed by a charge-remote fragmentation 
mechanism [21]. Fragment ions corresponding to the 
ring system at m/z 303 (A) are not observed. This is in 
contrast to the positive-ion CID of BPDE-DNA and 
BPDE-peptide adducts [22-241. The fragment ion at 
m/z 272 is significant and probably corresponds to 
fragmentation of the C-S bond in cysteine with charge 
residing on the peptide (“p). The next intense peak 
appears at m/z 171 (‘X2 p). This corresponds to a 
peptide ion formed by fragmentation at the C-S bond 
of cysteine and the bond between the carbonyl and 
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Figure 1. CID spectra of the [M - H)- ion of BPDE-10-GSH 
(m/z 608). (a) 400-eV collisions with Xe; spectrum recorded with 
the OATOF. (b) 4000-eV collisions with He; B/E linked scans 
recorded with the array detector. 
CH, groups of glutamic acid. A further intense peak 
appears 28 u below this at m/z 143 (‘Y2 p), as a 
consequence of the further loss of CO. Peptide frag- 
mentation continues to give peaks at m/t 128 (‘W,) 
and m/z 115 (Z,cw). Low mass fragment ions appear at 
m/z 100, 86, 74, and 57, characteristic of the glu- 
tathione fragments C,H,OaN (“Xi) or C,H60,N, 
C,H,O,N, C,H,O,N, and C z HO,, respectively. 
The 4000-eV CID spectrum of BPDE-lo-GSH (Figure 
lb) is similar to that recorded at 400 eV. There are 
however some significant differences. In the 4000-eV 
collision, intense M-46 and M-76 fragmentations (see 
Other Ions in the CID Spectra in Table 2) occur, and a 
triplet appears at m/z 304 (“y), 305 (‘r), and 306 (y). 
Each ion is probably formed by fragmentation of the 
C-S bond with charged residing on the peptide frag- 
ment. Fragmentation of this bond has been found to 
give ions at m/z 305 in the CID of the glutathione 
conjugate leukotriene (LTC,) 1211 and 306 in the CID 
of xenobiotic glutathione conjugates [25]. The fragment 
ion at m/z 260 is considerably more intense in the 
4000-eV spectrum than in the 400 eV and probably 
corresponds to the fragment CK (Scheme I>. The peptide 
fragmentations in both spectra are similar; however, 
fewer low mass peptide fragment ions are observed at 
4000 eV than at 400 eV. 
The CVCID spectrum of BPDE-IO-GSH was also 
recorded and is described in Table 2. There are many 
similar features between this, and the 400- and 4000-eV 
CID spectra. The most noticeable difference in the 
CVCID spectrum as opposed to the 4000- and 400-eV 
CID spectra is the almost complete absence of peptide 
fragments in the CVCID spectrum. The only significant 
peptide fragmentation is at “p. Care must be taken 
when drawing conclusions from CVCID spectra as 
contaminant ions may be present that introduce confu- 
sion to the interpretation of the spectrum. 
OH 
bn 
AS mfz 335’ ‘AS nu’z 334. 
AS-2H20 m/z 299** 
S‘ 
AS-H20 m/z 3,,** 
AS-48 m/z 287” 
A-2+0 m/z 2671 A-46 m/z 257*X 
Scheme I. Fragmentation of BPDE-GSH. The peptide has been 
drawn conjugated to the BP-trio1 at position 10. Drawn for the 
lo-isomer (*), the 7-isomer (**I, or the positional isomer (#). 
The 4000- and 400-eV CID spectra of the BPDE-7- 
GSH are shown in Figure 2. Although they are similar 
to those of the BPDE-lo-GSH, there are reproducible 
differences that aliow isomer differentiation. The most 
striking difference in the CID spectra of the two iso- 
mers is the presence of a much stronger fragment ion 
at m/z 299 (AS-2H,O) from BPDE-7-GSH than from 
BP-lo-GSH. This a characteristic of the CID of the 
BPDE-7-cysteinyl conjugates studied (Table 21, as are 
the enhanced intensities of fragment ions at m/z 317 
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Table 2. Mass-to-charge ratio of fragment ions formed in the CID of deprotonated molecules of BPDE conjugatesa 
lo-GSH 7-GSH 1 0-CysGly 1 0-NAcCys 
M-H 608 608 479 464 
AS 335 (141C 
‘AS 334 t-t 
AS-18 317 (3) 
Y 306 (3) 
‘Y 305 (39) 
AS-36 299 (7) 
AS-48 287 C-1 
A-18 285 (5) 
AS-52 283 (7) 
A-28 275 (3) 
“P 272 (30) 
A-36 267 (5) 
‘a 259 (4) 
A-46 257 (8) 
A-64 239 (3) 
&HI, 226 (4) 
A-88 
‘Xl, 
Z2Q 115 (100) 
y- 60 
“X , 100 (14) 
C,H,O*N 86 (19) 
C,H,O,N 74 (24) 
C,H,O, 59 (12) 
C,HO, 57 (13) 
(23td 
(18) 
(6) 
(94) 
(37) 
(28) 
t-1 
(15) 
(23) 
(8) 
(100) 
(15) 
i-j 
(15) 
(8) 
(17) 
(25) 
(6) 
(3) 
t-1 
(2) 
t--j 
(7418 
t-4 
(20) 
(19) 
(19) 
(100) 
(12) 
(13) 
(52) 
(46) 
(93) 
(55) 
(-) 
(55) 
(20) 
k-1 
(2) 
(-) 
(---I 
t-1 
(-) 
(-) 
335 (21) 
334 (11) 
317 (8) 
306 (8) 
305 (50) 
299 (37) 
287 (2) 
285 k-1 
283 (17) 
275 (-1 
272 (60) 
267 (5) 
259 (5) 
257 (5) 
239 (5) 
226 (5) 
215 (-1 
(16) 
(18) 
(11) 
(52) 
(lot 
(100) 
(10) 
t-1 
(38) 
(18) 
(90) 
(11) 
t-1 
k-1 
t-1 
(4) 
(8) 
(14) 335 
(-1 334 
(5) 317 
(13) 177 
t-1 
(48) 299 
t-1 
(-1 285 
(lot 283 
t-1 275 
(100) 143 
(10) 267 
t-1 130 
(-1 257 
f--j 239 
t--j 
t-1 215 
(36) 
(-) 
(5) 
(29) 
(16) 
(28) 
(11) 
(8) 
(100) 
(14) 
(32) 
(15) 
(8) 
t-1 
115 (100) (10) f--j 115 (95) 
100 (21) (13) (-) 100 (26) 
86 (18) f-t (-) 86 (10) 
74 (38) (2) t-1 74 (41) 
59 (6) t-1 c-t 59 (46) 
57 (16) f-t t-t 57 (31) 
(100) 
(48) 
(18) 
(62) 
(70) 
(55) 
(44) 
(16) 
(64) 
(30) 
(19) 
(16) 
(18) 
(61) 
(22) 
(18) 
t-t 
(4) 
i--j 
(2) 
(60) 335 (100) 
k-4 334 (7) 
(22) 317 (11) 
t---t 162 (11) 
161 (12) 
(1001 299 (5) 
(51) 285 (6) 
(37) 283 (26) 
(37) 275 (22) 
f-1 128 (5) 
(72) 267 t-1 
i-1 115 (2) 
(15) 257 (9) 
(98) 239 (7) 
226 t-1 
(62) 215 (2) 
146 (95) 
f-t 
102 (30) 
t-1 
t-t 
t-t 74 (47) 
i-1 59 (51) 
(4 57 (7) 
(100) 
(30) 
(10) 
(16) 
t-1 
(6) 
(6) 
(13) 
(12) 
(3) 
(3) 
(1) 
(6) 
(5) 
(3) 
(3) 
(7) 
(1) 
t-1 
6-j 
t-t 
(44) 
t-1 
(17) 
(-) 
t-1 
(100) 
1-J 
(73) 
(26) 
k-1 
(38) 
t-t 
(100) 
(47) 
(4 
(2) 
t-1 
t-1 
t-1 
t-1 
(-) 
Other Ions in the CID Spectra 
BPDE-lo-GSH 
m/z 563 M-46 (1) (57) (-1; 533 M-76 (--)(25t I-); 304 y (-) (48) (13); 260 a (5) (54) t-t; 203 t--t (I 0) (-1; 
185 (4) (6) (--I; 160 (7) (3) (k-1; 171 ‘X, @ (20) (15) (6); 145 (16) (6) t-t: 143 ‘Y, j3 (31 t (39) (9); 128 ‘W, (49) (16) (-1 
BPDE-7-GSH 
m/z 563 M-46 (4) (20) f-t; 533 M-76 t-t (18) (-1; 304 y t-t (31 t (5): 260 (Y (5) (35) (-); 203 (-t(7) (-1; 185 (7) (4) (-1; 
160 (8) (2) t-t; 171 ‘X2 p (27) (9) t-1; 145 (18) t-t t-1; 143 ‘Y, p (64) (40) t-t; 128 ‘W, (78) (32) (-) 
BPDE-lo-CysGly 
m/z 175 “y (12) (49) k-t; 243 A-60 (21 t (40) (42); 160 (19) (6) i--t 
BPDE-lo-NAc-Cys 
m/z 271 AS-64 (5) (6) (-1; 247 AS-88 (7) (6) (66); 243 A-60 (5) (4) t--j; 117 ‘y-44 (36) (3) (-) 
BPDE-7-NAcCys 
m/z 345 M-l 20 (-I(1 1) t-1; 269 A-34 (9) (-1 l-t; 255 A-48 (9) f--J (30); 117 ‘y-44 (30) (-I(-) 
BPDE-NAcCys (rat urine) 
m/z 255 A-48 (1 Ot (-If-t; 117 ‘y-44 (12) (-1 t--j 
(continued) 
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Table 2. (Continued) 
7-NAcCys U-NAcCysb lo-cys 7-cys 
M-H 464 464 422 422 
AS 
'AS 
AS-18 
Y 
'Y 
AS-36 
AS-48 
A-18 
AS-52 
A-28 
"P 
A-36 
'a 
A-46 
A-64 
&HI, 
A-88 
'Xly 
ZL?a 
y- 60 
x , 
C,H,O,N 
C,H,O,N 
COW', 
C,HO, 
335 (100) (100) (20) 
334 (9) (391 (20) 
317 (42) (40) (43) 
162 (10) (28) (7) 
161 (12) (4) f-1 
299 (121 (28) (100) 
287 (10) (15) (27) 
283 (28) (21) (80) 
128 
267 
115 
(17) 
(7) 
(1) 
(10) 
(4) 
(94) 
(20) 
(47) 
(17) 
(7) 
03) 
(1) 
239 
215 
146 
102 
74 
59 
(11) 
(10) 
(7) 
t-1 
(-) 
(4) 
(6) 
(73) 
t-1 
(57) 
i--j 
(6) 
t-1 
I-) 
(-) 
335 
334 
(100)" 
110) 
162 (10) 
335 (100) (100) 
334 c-4 (45) 
317 (34) (36) 
120 (27) (12) 
299 (201 299 (26) (18) 
283 (18) 
275 (10) 
128 (16) 
285 (28) (25) 
283 (33) (23) 
275 (32) (16) 
267 (25) (15) (100) 
115 (-) 
239 (-) 
257 (18) (12) (69) 
239 (32) (6) (100) 
215 l-1 
146 (61) 
215 t-1 
102 
74 
59 
(11) 
(34) 
(13) 
(8) (-) 
59 (80) 
(12) 
74 
(3) 
- - 
(55) 335 (64) 
t-1 
(24) 317 (100) 
C-1 120 (17) 
(76) 299 (35) 
(48) 
(76) 283 (14) 
(24) 
(451 215 (31) 
(21) 
t-1 
aRelative intensities are shown in parentheses. Peptide fragmentations are described in Schemes I and III 
‘BPDE-NAcCys in rat urine. 
‘In the 400.eV CID spectra. 
‘In the 4000-eV CID spectra. 
eln the CVCID spectra. 
(AS-H,O) and 287 (AS-48) and the reduced intensity of 
ions at m/z 285 (A-H,O) and 257 (A-46). Interestingly 
the fragment ions AS-2H,O, AS-H,O, and AS-48 are 
all sulfur-containing ions, while A-H,0 and A-46 are 
Figure 2. CID spectra of the [M - HI- ion of BPDE-7-GSH 
(m/z 608). (a) 400-eV collisions with Xe; spectrum recorded with 
the OATOF. (b) 4000-eV collisions with He; B/E linked scans 
recorded with the array detector. 
not. The two BPDE-GSH isomers can thus be differen- 
tiated from their 4000- or 400-eV CID spectra. 
The CVCID spectrum of BPDE-7-GSH is similar to 
that of BPDE-IO-GSH. The interpretations of the CID 
spectra of the BPDE-GSH isomers is greatly aided by 
comparison with the CID spectra of LTC, recorded 
under identical instrumental conditions [26]. All ions 
assigned as peptide fragments are observed in the 
spectra of LTC,. Furthermore, as can be seen from 
Table 2, the ions proposed to be formed by fragmenta- 
tion of the BP-trio1 are common to the spectra of other 
BPDE-cysteinyl conjugates. 
There have been comparatively few studies of the 
CID of conjugated BP metabolites. Gross and co- 
workers 1221 have investigated the CID reactions 
BPDE-DNA adducts, while Zaia and Biemann [23] 
have investigated the fragmentation reactions of other 
BPDE-peptide adducts. In both of these studies posi- 
tive-ion FAB was the method of ionization and kilo- 
electronvolt CID reactions of [M + HI+ ions were in- 
vestigated. In Gross’s work on BPDE-DNA adducts, 
CID spectra of BPDE-IO-Gua and BPDE-lo-Ade were 
recorded. These were dominated by intense peaks at 
m/z 303 (A) corresponding to the BP-trio1 and at m/z 
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285 (A-H,O), 257 (A-46), and 239 (A-64) resulting from 
losses of H,O, CO, and a second H,O from the trio1 
portion of the molecule (Scheme II). Zaia and Biemann 
in their study also observed these fragment ions and 
also an ion at 267 (A-2H,O). In both of these positive- 
ion studies [M + H - 302]+ ions were observed. 
Branco et al. [24] investigated the positive-ion FAB, 
low energy CID of BPDE-DNA adducts. Their results 
were essentially similar to those of Gross and co- 
workers [22], indicating that the formation of ions at 
m/z 303, 285, 257, and 239 and corresponding to 
[M + H - 302]+ are low energy processes. In our neg- 
ative-ion CID spectra of the conjugated MP metabo- 
lites [M - H - 3021~ ions (7) were predominantly 
observed in the 4000-eV spectra although they were 
also present to a lesser extent in the 400-eV spectra. In 
spectra recorded at collision energies of 400 or 4000 eV 
there was no evidence of peaks at m/z 303, but the 
presence of fragment ions at m/z 285 and 257 is 
characteristic of BPDE-10 conjugates while peaks at 
m/z 267 and 239 were present in the spectra of BPDE- 
10 and BPDE-7 conjugates. 
Collision-Induced Dissociation of BPDE-ZO-CysGly, 
BPDE-ZO-NAcCys, BPDE-7-NAcCys, 
BPDE-IO-Cys, and BPDE-7-Cys 
CID spectra of the BPDE-CysGly, BPDE-NAcCys, and 
BPDE-Cys isomers are described in Table 2 and 400-eV 
CID spectra of BPDE-lo-NAcCys and BPDE-7-NAcCys 
are shown in Figure 3 (see also Scheme III) Their 
interpretation is simplified by taking into account the 
CID spectra of the GSH conjugate and those of cys- 
teinyl leukotrienes previously reported [21, 261. The 
CID spectra of all BPDE-10 conjugates are very similar. 
The only significant differences result from fragmenta- 
tion of the different peptide-conjugating groups. The 
Am/Z?03 
OH 
Figure 3. CID spectra of the [M - HI- ion of BPDE-NAcCys 
(WI/Z 464). 400-eV collisions with Xe; spectra recorded with the 
OATOF. (a) BPDE-lo-NAcCys; (b) BPDE-7-NAcCys; (c) from the 
medium acidic fraction of germ-free rat urine. 
BPDE-7 conjugates can readily be differentiated from 
the BPDE-10 conjugates. The BPDE-7 conjugates show 
characteristic enhanced intensity of fragment ions at 
m/z 317,299, and 287, and the reduced intensity of the 
ions at 285 and 257 in their spectra. 
The CVCID spectra of the BPDE-cysteinyl adducts 
have also been recorded, and are described in Table 2. 
The BPDE-NAcCys isomers can be differentiated by 
the presence of peaks at m/z 285 and 257 in the 
spectrum of the BPDE-lo-NAcCys isomer but not that 
of BPDE-7-NAcCys isomer. 
CH 
3 
r”” ,NH. B 
A-2”20 ti 267# A46 mdZ257# 
Scheme II. Fragment ions formed in the CID of [M + HI+ 
BPDE-adducts [22, 241. 
bH 
Scheme III. Fragmentation of BPDE-NAcCys. The peptide has 
been drawn conjugated to the BP-trio1 at position 10. 
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Figure 4. CID spectra of the [M - HI- ion of BP-9-SO, (m/z 
347). (a) 400.eV collisions with Xe; spectrum recorded with the 
OATOF. (b) 4000-eV collisions with He; B/E linked scans 
recorded with the array detector. 
Collision-Induced Dissociation of BP-g-Sulfate and 
BP-6-Sulfate 
The CID spectra of the BP-9 sulfate is shown in Figure 
4 (see Scheme IV). The fragmentation patterns ob- 
served at 400- and 4000-eV collision energies are simi- 
lar. The only significant difference in the two spectra is 
in the intensity of fragment ions. In the 400-eV spec- 
trum the dominant fragment ions are at m/z 267 
(BPO) and 80 (SO,), while in the 4000-eV spectrum the 
0- 00 
Yl5?? 
000 
BP0 &XV Q m/z 282*# 
dominant fragment ions are at m/z 267 (BPO), 282 
(Q), and 254 (Q-CO). 
The CID spectra of BP-6-SO, (Figure 5) are very 
different from those of BP-9S0,. The 400-eV spectrum 
of BPd-SO, is completely dominated by the SO, frag- 
ment ion at m/z 80. Other minor fragment ions are at 
282 (Q) and 267 (BPO). In this spectrum the BP0 and 
Q fragment ions have similar intensities, while in the 
corresponding spectrum of the BP-PSO, isomer the 
BP0 fragment was 50 times more intense. 
The 4000-eV spectrum of BPB-SO, (Figure 5b), like 
the 400-eV spectrum, shows an intense fragment at 
m/z 80. However, this spectrum is dominated by a 
fragment ion at m/z 282 (Q). The Q fragment in this 
spectrum is five times more intense than the BP0 
fragment. From the CID spectra recorded at both 4000 
and 400 eV the two BP-SO, isomers can be easily 
differentiated. 
The CVCID spectra of the two isomers are also 
different. The CVCID spectrum of BP-9-SO, is domi- 
nated by the BP0 fragment as were the 400- and 
4000-eV spectra of the isomer. The CVCID spectrum of 
BPB-SO, shows an intense fragment ion at m/z 282, 
the characteristic fragmentation of BPB-SO,. 
Collision-Induced Dissociation 
of BP-9-Glucuronide, BP-6-Glucuronide, 
and BP-3-Glucuronide 
Neither the 4000- or 400-eV CID spectra allow the 
differentiation of the three BP-GlcA isomers. The 400- 
eV spectra are dominated by the BP0 fragment (m/z 
267) (Figure 6; Scheme Vf. At low mass, glucuronic 
acid fragment ions are observed. The 4000-eV spectra 
are similar to those recorded at 400 eV; however, the 
relative intensities of glucuronic acid fragments are 
reduced. The CVCID spectra of the three isomers are 
also indistinguishable, the only major fragment being 
at m/z 267. 
Q-CO dz -zs.vx Q mk282-# 
Scheme IV. Fragmentation of BP-SO,. The sulfate has been 
drawn conjugated to the BP at position 9. Drawn for the 9-isomer 
(“1, the 6-isomer (**), or the positional isomer (#). 
Figure 5. CID spectra of the [M - HI- ion of BP-6-SO, (m/z 
347). (a) 400-eV collision with Xe; spectrum recorded with the 
OATOF. (b) 4000-eV collisions with He; B/E linked scans 
recorded with the array detector. 
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Figure 6. 
(m/z 443) 
OATOF. 
CID spectrum of the [M - HI- ion of BP-9-GlcA Scheme V. Fragmentation of BP-GlcA. The glucuronide has 
400~eV collisions with Xe; spectrum recorded with the been drawn conjugated to the BP at position 9. 
Gross and co-workers [22] also studied BP-6 
adducts. They recorded CID spectra of the [M + HI + 
ions of BP-6-N7Gua, BP-6-C8Gua, BP-6-NLdG, and BP- 
6-N7Ade and from them it was possible to differenti- 
ate between different isomers, for example, BP-N7Gua 
from BP-C8Gua, by differences in the ratio of two 
characteristic fragments at m/z 252 and 277. These 
ions correspond to BP radical cations and BP-CN radi- 
cal cations. In the CID spectra of the [M - HI- ions of 
the BP-SO, and BP-GlcA isomers recorded in the pres- 
ent work BP radical anions were not observed, but 
BP-O fragment ions were observed in the spectra of 
all isomers. 
Sensitivity of Negative-Ion Collision-induced 
Dissociation for the Analysis 
of Conjugated BP Metabolites 
A systematic study has not been made to determine 
the minimum amount of sample required to record a 
structurally informative CID spectrum. The aim of the 
present CID study was to investigate the fragmenta- 
tion reactions of conjugated BP metabolites and thus 
spectra presented in Figures l-6 were obtained from 
large quantities of sample (approximately 200 ng). 
However spectra containing the major fragment ions 
could be obtained from picomoles of infused sample. 
Structure Determination of Conjugated BP 
Metabolites in the Urine of Germ-Free Rats 
by Using Micro-High-Performance Liquid 
Chromatography-Electrosprny Mass 
Spectromety-Collision-Induced Dissociation 
Our previous study on BP metabolism in vivo by 
using ion exchange chromatography has shown that 
about 80% of the urinary metabolites of BP are in a 
conjugated form [7, 81. Of these, 20% were sulfate 
conjugates eluting as strong acids and 40% were glu- 
curonides and NAcCys conjugates eluting as acids of 
medium strength. By using capillary column HPLC-ES, 
mass spectra were recorded. By comparing the mass 
spectra of each component in each chromatographic 
fraction, collected from urine before and after BP ad- 
ministration, BP conjugates were identified in the com- 
plex mixture of endogenous compounds. In ongoing 
work, micro-HPLC-ES with CID is used to provide 
structural information concerning the various urinary 
conjugated BP metabolites. 
As an example of this application of the methodol- 
ogy to the in vivo situation, the fraction from germ-free 
rat urine-containing acids of medium strength gave an 
intense ion at m/z 464 after but not prior to the 
administration of BP. The 400-eV CID spectrum of this 
ion was recorded and is described in Table 2 and 
shown in Figure 3c. The compound was identified as a 
BPDE-NAcCys isomer. A group of low mass peaks 
(m/z 59,74,102,117,128,146, and 162) were observed 
which are characteristic of the NAcCys conjugating 
group. The most intense fragment is at m/z 335, 
which is characteristic of the tetrahydro-trihydroxy- 
sulfur modified BP ring (AS). However, the precursor 
ion does not appear to correspond to BPDE-lO-NAc- 
Cys or BPDE-7-NAcCys as its fragmentation pattern, 
although similar to those of the isomers studied, is not 
identical. The most pronounced difference between the 
spectra is the greatly reduced intensity of the fragment 
ion at 317 in the CID spectrum of the metabolite in rat 
urine. Analysis of further reference compounds will be 
required to determine the position of conjugation. 
ColIision Energy Effects on Collision-Induced 
Dissociation Reactions 
As mentioned above, the CID spectra recorded as B/E 
linked scans at a collision energy of 4000 eV showed 
differences from those recorded on the OATOF at 
collision energies of 400 eV. The major differences 
between the 400- and 4000-eV CID spectra of the 
conjugated BPDEs concerned the intensity of the low 
mass peptide fragment ions; otherwise the spectra 
recorded at the two collision energies are very similar. 
A comparable situation pertains to the CID of the 
isomers of BP-GlcA and BP-SO,, where the intensity of 
the low mass fragment ions is accentuated in the 
400-eV CID spectra. 
CID reactions are often discussed in terms of center 
of mass collision energies ( E,, > and laboratory frame 
of reference collision energies (Elab). E,, values are 
calculated by using the equation 
J Am Sot Mass Spectrom 1997, 8, 50-61 
Table 3. Center of mass collision energies calculated for the 
CID of BP metabolite conjugates 
CID OF CONJUGATED BENZO[a]PYRENE METABOLITES 
References 
BP-Metabolite 
BPDE-GSH 
BPDE-CysGly 
BPDE-NAcCys 
BPDE-Cys 
BP-sulfate 
BP-glucuronide 
4-keV 400.eV 300-eV 
Collision Collision Collision 
with HE with Xe with N, 
26 71 13 
33 86 17 
34 89 17 
38 95 19 
46 110 22 
36 92 18 
1. 
2. 
3. 
4. 
5. 
6. 
where Elab is the initial kinetic energy of the projectile 
ion, mP is the mass of the projectile ion, and mcg is the 
mass of the collision gas. 
7. 
8. 
Values of E,, give the maximum theoretical amount 
of the projectile ions translational energy that can be 
converted into internal energy as the result of the 
collision, and those calculated for the collision reac- 
tions studied are given in Table 3. Very often CID 
spectra recorded at quite different laboratory frame 
collision energies but with center of mass collision 
energies above a certain threshold give similar spectra. 
This has been shown to be true of peptides [27], fatty 
acids [28], and leukotrienes [21, 261 and also holds for 
conjugated BPDE and BPS. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
Conclusion 
16. 
Micro-column HPLC interfaced to a hybrid magnetic 
sector tandem mass spectrometer with electrospray 
ionization is a promising method for the study of 
intact conjugated BP metabolites. With a focal plane 
array detector, detection limits were at the femtomole 
level. This will allow us to detect labile conjugated BP 
metabolites in biological samples at trace levels. Struc- 
ture elucidation of individual BP conjugates was 
achieved by CID. The CID spectra can be used not 
only to determine the type of conjugation of BP 
metabolites, but also in some cases the position of 
conjugation. 
17. 
18. 
19. 
20. 
21. 
22. 
23. 
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